Psychiatrists Anxious to Treat All Child-bearing Women for Post-Partum Depression

The FDA approved the first drug treatment for post-partum depression (PPD) on March 19, 2019. Psychiatrists call this “peripartum depression”, which means depressive symptoms during pregnancy or after childbirth. While there is no  actual diagnostic test for this, the current revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) labels this with various alternative wordings of “depressive disorder” or “bipolar disorder” or “anxiety disorder” or “stress disorder,” sometimes with the specifier “with peripartum onset“, depending on the circumstances.

The diagnosis is totally subjective, and is a justification for making money for prescribing an antidepressant. Psychiatrists do not typically perform any clinical tests to find out if there is a real medical reason for the symptoms, such as thyroid problems or vitamin deficiencies. Research suggests that rapid changes in hormones and thyroid levels during and after delivery have a strong effect on moods, yet this is mostly ignored by the psychiatric industry since it is easier and more profitable to prescribe a psychotropic drug.

The drug is Zulresso (generic brexanolone), an intravenous infusion administered continuously over 60 hours (2.5 days) and requiring constant monitoring. There is a risk of serious harm due to a sudden loss of consciousness during the treatment, the appearance of suicidal thoughts and behaviors, or hypoxia (loss of oxygen in the blood). The drug passes into breast milk, but there is no data on the safety of brexanolone while breastfeeding. The cost has currently been set at $34,000 per course of treatment.

Sage Therapeutics says that this neurosteroid, a derivative of allopregnanolone, affects GABAA (Type-A gamma-Aminobutyric acid) neurotransmitter receptors in the brain, although the actual mechanism of action of this drug with respect to PPD (or any other condition) is unknown.

Many people think that post-partum depression is a mental illness. However, this is very misleading for a mother who has experienced the trauma of just giving birth. To have them think the emotional roller coaster they may be experiencing is the result of a “chemical imbalance in the brain,” requiring mind-altering medication, is false and potentially very harmful.

This does not mean that serious emotional difficulties do not exist. But it does mean that psychiatrists and psychologists have used such difficulties to their advantage, promoting powerful drugs as a “solution” for vulnerable individuals. This has been for the sake of profit, often at the expense of people’s lives.

Quite apart from such drugs causing harm, they are also unnecessary. Any competent medical doctor who takes the time to conduct a thorough physical examination of someone exhibiting signs of what psychiatrists say are “mental disorders,” including post-partum depression, can find undiagnosed, untreated physical conditions.

Instead, psychiatrists prefer to tell young mothers that their condition is an “illness,” requiring “medication,” potentially endangering the life of the mother and her child.

Women may experience drastic drops in hormone levels after the birth of a child that can deliver a major shock to the woman’s body. Nutritional and mineral depletion or deficiencies as well as a lack of sleep while caring for a baby can also cause the symptoms psychiatrists say are a “mental disorder.” It can be treated nutritionally.

For more information, download and read the CCHR bookletThe Drugging of ‘Post Partum Depression’ – Clearing up Misconceptions About ‘Chemical Imbalances,’ Antidepressant Drugs and Non-Drug Solutions“.

You’re Not Paranoid, It’s Really Happening

Abilify Mycite® (aripiprazole tablets with sensor, from Otsuka Pharmaceutical) is a prescription drug of an aripiprazole tablet (an atypical antipsychotic) with a metallic Ingestible Event Marker (IEM) sensor inside it, used in adults for diagnoses of schizophrenia, bipolar I disorder, and major depressive disorder. A month’s supply of it costs around $1,650. The actual mechanism of action of aripiprazole is unknown, although it messes with the levels of dopamine and serotonin in the brain, which is playing Russian Roulette with your mind.

The sensor is intended to track, with a smartphone app, if the drug has been taken. The ability of this drug to improve patient compliance or modify dosage has not been established. The only thing the FDA approved was functions related to tracking drug ingestion. The use of this drug to track drug ingestion in real-time or during an emergency is not recommended because detection may be delayed or not occur.

The drug sends information to a patch worn on the patient’s arm, which is then logged on a mobile app, which then sends the data to their doctor. Some experts warn that the idea of swallowing a tracking chip may be too much for paranoid patients to handle.

Said one expert, “I am concerned about the formation of new pharmaceutical persons who are digitally enhanced to be compliant with the profit motives of corporations and the directives of health providers and drug companies. … The fact that the drug is Abilify, which is prescribed to people who experience serious mental distress, should raise many ethical red flags. These concerns are especially relevant because the patent for the original Abilify drug expired in 2016… My concern is that … the company will be motivated to profit from the technology as much as possible, regardless of whether the drug actually improves health.”

The idea for this gross invasion of privacy comes about because refusing to take prescribed drugs is a particular psychiatric concern, and is even enshrined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as “Nonadherence to medical treatment.”

Abilify MyCite is still not widely used in the US, possibly because of skepticism from patients, prescribing doctors and insurance providers, although Otsuka has collaborated with Magellan Health to roll the drug out to the US, and UnitedHealthcare has developed complex rules for insurance authorization.

This drug has potentially severe side effects including stroke; akathisia; neuroleptic malignant syndrome; tardive dyskinesia; unusual urges such as compulsive gambling, sex, eating, or shopping; seizures; suicidal thoughts or behaviors. Side effects may be considerably more severe with known CYP2D6 poor metabolizers (a Cytochrome P450 enzyme.)

This drug also has a Boxed Warning about an increased risk of suicidal thinking and behavior in children, adolescents and young adults.

Recognize that the real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior as “diseases.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax — unscientific, fraudulent and harmful.

If you are taking this drug, do not stop suddenly. You could suffer serious withdrawal symptoms. You should seek the advice and help of a competent medical doctor or practitioner before trying to come off any psychiatric drug.

Set It and Forget It Birth Control

We’ve recently been seeing frequent TV ads for Kyleena and Mirena, intrauterine devices (IUDs) that slowly release a progestin hormone called levonorgestrel into the uterus to prevent pregnancy, sometimes referred to as “Set it and forget it birth control.”

Interestingly enough, the manufacturer of levonorgestrel tablet contraceptives (Plan B) says “This medication is an emergency contraceptive and should not be used as a regular form of birth control.”

Possible adverse side effects from these IUD devices include ovarian cysts, abdominal/pelvic pain, headache or migraine, acne, breast tenderness or pain, heavier bleeding, depression, changes in hair growth, and hair loss.

The potential for depression as a side effect caught our attention.

Then the May 2019 Scientific American was published with several articles about birth control, indicating that the occurrence of bad side effects from IUDs are much higher than one might suspect.

One article brought it even closer to our home, saying that “Much of the recent enthusiasm over IUDs can be traced back to a single study called the Contraceptive CHOICE research project [2007-2011]. Funded in part by a then anonymous donor now known to be the Susan Thompson Buffett Foundation and facilitated by Washington University in St. Louis, the project had the explicit goal of increasing the use of LARC [Long-Acting Reversible Contraception] among women at high risk of unintended pregnancy.”

Obviously we are not advocating for or against anything related to birth control; our sole interest is in how the psychiatric industry may be involved. And with depression as a side effect of these devices, we have a clue.

We’ve all heard the term Premenstrual Syndrome (PMS), which includes symptoms such as mood swings, irritability and depression. Current thinking is that over 90% of women get some PMS adverse side effects.

Naturally, if psychiatrists can prescribe a drug for it, they will include it in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) so that insurance will pay for diagnosing it and prescribing a drug.

So what does the DSM have to say about it? Here are some possible related diagnoses:

— Premenstrual dysphoric disorder [dysphoric means “a state of unease or dissatisfaction”]
— Problems related to unwanted pregnancy
— Depressive disorder due to another medical condition
— Unspecified depressive disorder
plus another 75 disorders related to depression of one kind or another.

All of these fraudulent diagnoses can be used to prescribe an antidepressant or some other harmful and addictive psychiatric drug, none of which actually address the root cause of the condition.

Need we actually say that premenstrual dysphoric disorder, or PMS, is not a “mental illness” requiring an antidepressant? Need we actually say that a depressive side effect of an IUD is not a “mental illness” requiring an antidepressant?

Well, we’ve said it anyway. Protect yourself from psychiatric fraud and abuse by insisting on Full Informed Consent with your doctor.

Shock and Awe – the Latest Psychiatric Abuse of Children

Shock and Awe is a tactic based on the use of overwhelming power and spectacular displays of force to paralyze an enemy.

Now the psychiatric industry is introducing electrical “stimulation” of children’s brains as a socially acceptable gradient to just plain shocking them into good behavior.

The U.S. Food and Drug Administration (FDA) approved on April 19, 2019 a medical device for so-called attention deficit hyperactivity disorder (ADHD). The prescription-only device, called the Monarch external Trigeminal Nerve Stimulation (eTNS) System from NeuroSigma, is for patients ages 7 to 12 years old who are not currently taking prescription ADHD drugs. It was originally developed at the University of California, Los Angeles, to reduce epileptic seizures. Research continues on using eTNS for epilepsy, depression, migraine, PTSD, and ADHD.

This device delivers an electric current to the brain (through the V1 branch of the 5th cranial nerve) with an electrode taped to the forehead. It costs about $900 to start, with additional costs for more of the electrode patches which are only used once each. It is not currently reimbursed by insurance.

While the exact mechanism of how eTNS is supposed to work is not known, one physical effect is apparently to increase blood flow in certain areas of the brain and decrease it in others. They recommend using it daily for up to four weeks before any significant changes are observed; we could not find any information about long-term effects or whether any changes are observed after treatment is stopped. It was clinically tested in 2017 in the U.S. for this FDA approval, paid for by a grant from the U.S. National Institute of Mental Health, on 62 children for four weeks. The most common side effects observed were drowsiness, an increase in appetite, trouble sleeping, teeth clenching, headache and fatigue.

Results were recorded during clinical testing by asking the child to answer questions on the ADHD Rating Scale (ADHD-RS) such as whether they have difficulty paying attention or regularly interrupt others. Ratings of ADHD symptoms on various rating scales are entirely subjective, as are the diagnostic criteria for ADHD.

A prior feasibility study in 2015 was performed with 24 children for 8 weeks, using the ADHD-IV Rating Scale. It did not establish the durability of treatment effects following discontinuation of treatment, either.

To be blunt, ADHD is a fraudulent “disease.” In 1987, ADHD was literally voted into existence by a show of hands of American Psychiatric Association members and included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V). Within a year, 500,000 children in America alone were diagnosed with this, and to expand the client base it has also been associated with Asperger syndrome and Autism spectrum disorder.

ADHD actually represents the spontaneous behaviors of normal children. When these behaviors become age-inappropriate, excessive or disruptive, the potential causes are limitless, including: boredom, poor teaching, inconsistent discipline at home, reading difficulty, tiredness, street drugs, nutritional deficiency, toxic overload, bullying, abuse, stress, and many kinds of underlying physical illness.

By making an ADHD diagnosis, we ignore and stop looking for what is really going on with the child. These children need the adults in their lives to give them additional attention and to find and treat the actual causes, rather than shock their brains to see if that “works.”

There are no workable ADHD drugs, either for children or for adults. This new “treatment” is supposed to be appealing because it does not use drugs, but guess what? They don’t know how it is supposed to work, either; and they haven’t tested it long enough to know the consequences of running an electric current into a child’s brain.

Aw shucks, no one denies that children can have difficult problems in their lives. Mental health care is therefore both valid and necessary. However, the emphasis must be on workable mental healing methods that improve and strengthen them by restoring personal strength, ability, competence, confidence, stability, responsibility and spiritual well-being. Psychiatric treatments are not workable; they are designed, with shock and awe, to overwhelm.

Chanting the Chantix Mantra

Recently there has been a gross increase in the TV ad campaign for Chantix, promoting this deadly drug for smoking cessation.

We’ve written about Chantix before, but we thought a repeat was in order due to this massive ad campaign.

In 2008 the Federal Aviation Administration banned Chantix for pilots and air traffic controllers, and reissued that decision in 2013.

The U.S. Food and Drug Administration (FDA) slapped a “Black Box” warning on Chantix (varenicline tartrate, made by Pfizer) in 2009 after receiving thousands of reports linking the drug to mental health issues, including suicidal thoughts, hostility and agitation.

In 2015, the FDA expanded the warning to note that the drug had also been linked to reduced alcohol tolerance leading to seizures.

However, in 2016 the FDA removed the Black Box warning, after heavy lobbying from Pfizer claiming that additional data showed that the benefits of Chantix outweighed its adverse side effects (oh, and since its sales had significantly dropped.)

But the adverse side effects did not go away; only the Black Box warning went away. One study found that Chantix had more cases of suicidal thoughts, self-harm, and homicidal thoughts than any other drug, by a more than three-fold margin. Pfizer’s prescribing information still warns about new or worsening mental health problems such as changes in behavior or thinking, aggression, hostility, agitation, depressed mood, or suicidal thoughts or actions while taking or after stopping Chantix.

We suspect that the recent spate of TV ads is related to the removal of the Black Box warning and the prior drop in sales. Also, the price of Chantix more than doubled between 2013 and 2018. In 2013, Pfizer paid out $273 million to settle a majority of the 2,700 state and federal lawsuits that had been filed over adverse side effects. Now the company is trying to grow the market with clinical studies for smokers age 12 to 19.

What is Chantix?

Chantix is a psychiatric drug — a benzodiazepine-based anti-anxiety drug, also called a minor tranquilizer or sedative hypnotic. Daily use of therapeutic doses of benzodiazepines are associated with physical dependence, and addiction can occur after 14 days of regular use. Typical consequences of withdrawal are anxiety, depression, sweating, cramps, nausea, psychotic reactions and seizures. There is also a “rebound effect” where the individual experiences even worse symptoms than they started with as a result of chemical dependency.

The exact mechanism of action of benzodiazepines is not known, but they affect neurotransmitters in the brain and suppress the activity of nerves, under the unproven theory that excessive activity of nerves may be the cause of anxiety. Chantix was developed to specifically affect nicotinic receptors in the brain, under the theory that this would reduce nicotine craving and block the rewarding effects of smoking. Messing with neurotransmitters in the brain is playing Russian Roulette with your mind.

Benzodiazepines are metabolized by cytochrome P450 enzymes, so a genetic lack of these enzymes can cause a buildup of harmful toxins and increase the severity of adverse side effects.

Psychiatric “best practices” consider that smoking is an addiction and recommend that psychiatrists assess tobacco use at every patient visit, since tobacco addiction is covered in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) as a “mental illness” under eight separate items, and disorders related to inhalant use have 33 entries. Smoking is not a mental illness and addiction cannot be fixed with psychiatric drugs.

The psychiatric industry considers that smoking cessation therapies are their territory, however this drug masks the real cause of problems in life and debilitates the individual, thus denying one the opportunity for real recovery and hope for the future. Treating substance abuse with drugs is a major policy blunder; contact your state and federal representatives and let them know you disapprove of this trend.

Recognize that the real problem is that psychiatrists fraudulently diagnose life’s problems as an “illness”, and stigmatize unwanted behavior like smoking as a “disease.” Psychiatry’s stigmatizing labels, programs and treatments are harmful junk science; their diagnoses of “mental disorders” are a hoax — unscientific, fraudulent and harmful. All psychiatric treatments, not just psychiatric drugs, are dangerous.

Depression and The Marketing of Madness

The high-income partnership between psychiatry and drug companies has created an $80 billion psychotropic drug profit center, requiring constant marketing to push harmful and addictive psychotropic drugs on a vulnerable public.

How did psychotropic drugs, with no target illness, no known curative powers and a long and extensive list of harmful side effects, become the go-to treatment for every kind of psychological distress? And how did the psychiatrists espousing these drugs come to dominate the field of mental treatment?

Clever marketing hides the harm in a succession of consumer ads constantly churning through “new revelations.”

The most recent we’ve seen have been these gems:

— A new marketing catchphrase is being used in a Trintellix commercial — “Depression is multiple symptoms.”

— Another new marketing catchphrase is being used in a Latuda commercial — “A different type of depression.”

Psychiatry continues heavily pushing false data about depression

The fact is, the American Psychiatric Association, the American Medical Association and the National Institute of Mental Health admit that there are no medical tests to confirm depression as a disease but do nothing to counter the false idea that these are biological/medical conditions when in fact, diagnosis is simply done by a checklist of behaviors.

There are 77 entries in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) using some variation of the word “depressive”, so that nearly anyone can be so diagnosed and prescribed harmful and addictive psychotropic drugs.

Yes, people experience various symptoms of mental distress. This does not make them “mentally diseased” and there is no evidence of physical/medical abnormality for the so-called diagnosis of “depression.” This doesn’t mean that there aren’t solutions for people experiencing difficulty; there are non harmful, medical alternatives. But they do not require a psychiatric “label” to treat them. There is no mental illness test that is scientifically/medically proven. This isn’t a matter of opinion — psychiatrists who are opposed to the labeling of behaviors as mental illness openly admit this.

Dr. Thomas Szasz said, “The term ‘mental illness’ refers to the undesirable thoughts, feelings, and behaviors of persons.” More properly, it is just what psychiatry and psychiatrists have inappropriately labeled as “undesirable behavior;” the prime undesirable antisocial people on the planet telling you what they think is undesirable!

Find out more about the fake “disease” called depression and the harm that anti-depressive drugs do.

Watch the documentary exposing the truth behind the slick marketing schemes and scientific deceit that conceal a dangerous and often deadly sales campaign.

The Marketing of Madness Education Package is the ultimate resource for educating others on the dangerous effects of psychotropic drugs, and the multi-billion-dollar psychiatric-pharmaceutical partnership now dominating the field of mental health. CCHR is offering this kit for free to educators and lecturers to assist them in educating others about the risks of these mind-altering drugs, and to furnish information that is generally not told to patients or physicians. Arm yourself with the facts about psychiatry.

Buds Worth Billions – Blinded by the Buds

The January 18-24 2019 edition of the St. Louis Business Journal extolled the virtues of making lots of money from medical marijuana.

Yes, we know that medical marijuana is now legal in Missouri; and yes, we know that the Business Journal‘s interest in local businesses motivates its attention.

On the other hand, a convincing argument can be made that, while legal and profitable, promoting marijuana is decidedly unethical.

“The Missouri Medical Cannabis Trade Association estimates $500 million in total economic benefit for the first year of the program.”

There are countless arguments for “medical benefits”; but those arguments seem to take second place after the arguments for how much money can be made.

There are also arguments for medical harm. Let’s take a look at the medical disadvantages, to get a sense of how promoting marijuana could be unethical.

Marijuana is a Drug

Make no mistake, marijuana (often called cannabis in an attempt to avoid the negative connotations of weed) is a drug.

Regardless of the name, this drug is a hallucinogen — a substance which distorts how the mind perceives the world.

THC (tetrahydrocannabinol), the principal psychoactive component of marijuana, stays in the body for weeks, possibly months, depending on the length and intensity of usage. THC damages the immune system. In 2005, 242,200 emergency room visits in the U.S. involved marijuana. Nationwide, 40% of adult males tested positive for marijuana at the time of their arrest for a crime. Multiple studies have linked years of heavy marijuana use to brain abnormalities and psychosis. Cannabis is one of the few drugs which causes abnormal cell division which leads to severe hereditary defects.

Because a tolerance builds up, marijuana can lead users to consume stronger drugs to achieve the same effects.

People take drugs to get rid of unwanted situations or feelings. The drug masks the problem for a time, but when the “high” fades, the problem, unwanted condition or situation returns more intensely than before. Marijuana can harm a person’s memory — and this impact can last for days or weeks. Marijuana smoke also has all of the detrimental effects previously attributed to tobacco.

The use of marijuana is not only harmful to the person himself; he can also become a risk to society. Research clearly shows that marijuana has the potential to seriously diminish attention, memory, and learning. Users have more accidents, more injuries, and absenteeism than non-users.

Some will tell you that CBD (cannabidiol) is harmless because it does not contain THC. However, note that CBD and THC are structural isomers, which means they share the same chemical composition but their atomic arrangements differ. The proponents of CBD ignore the fact that it messes with the neurotransmitter serotonin when making claims for its safety and usefulness. There are very little long-term safety data available, but there is a lot of money riding on making this legal and ubiquitous; any bad effects are not going to be advertised or promoted. At higher dosages, CBD will deactivate cytochrome P450 enzymes, making it harder to metabolize certain drugs and toxins, particularly psychiatric drugs, leading to a toxic build-up of drugs and their subsequent adverse side effects.

How Drugs Work in the Body

Drugs are essentially poisons. The amount taken determines the effect. A small amount acts as a stimulant. A greater amount acts as a sedative. An even larger amount poisons and can kill. This is true of any drug.

Drugs block off all sensations, the desirable ones along with the unwanted ones. While providing short-term help in the relief of pain, they also wipe out ability and alertness and muddy one’s thinking.

Drugs affect the mind and destroy creativity. Drug residues lodge in the fatty tissues of the body and stay there, continuing to adversely affect the individual long after the effect of the drug has apparently worn off.

The Psychiatric Connection

In 2013 the American Psychiatric Association said, “There is no current scientific evidence that marijuana is in any way beneficial for the treatment of any psychiatric disorder.” The research was starting to show significant harm from cannabis use.

However, the psychiatric industry today has jumped on the cannabis bandwagon for several reasons. Psychiatrists are embracing all things marijuana because they are getting so many patients with marijuana-related problems such as addiction and psychosis. Marijuana addiction is such a significant problem that there are 31 entries in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) related to this addiction. Unfortunately, the last thing any psychiatric treatment has achieved is rehabilitation from addiction.

Since the 1950’s, psychiatry has monopolized the field of drug rehabilitation research and treatments. Its long list of failed cures has included lobotomies, insulin shock, psychoanalysis and LSD.

To the psychiatric industry, when they are not prescribing it as a “treatment”, cannabis use merely represents another pool of potential patients for other coercive and harmful treatments.

The history of psychiatry makes it clear that over many, many years they have been pushing dangerous drugs as “medicines.” We didn’t originally know about the long-term destructive effects of LSD, heroin, ecstasy, benzodiazepines, ritalin, and so on when psychiatrists first pushed them onto an unsuspecting society. Cannabis is no exception, as more and more psychiatrists are prescribing “medical” cannabis in spite of (or because of) the addiction problem. We think it’s the latter; the pool of potential psychiatric patients is increased by increasing cannabis use.

The Ethics of Promoting Marijuana Use

Ethics consists simply of the actions an individual takes on himself. A high level of ethics enhances one’s survival across all areas of life; it embodies rationality towards the greatest good for the greatest number. A low level of ethics, on the other hand, would be one’s irrationality toward bringing minimal survival, maximum harm or destruction, across all areas of life — or the least good for the fewest. An individual whose actions are harmful in society becomes subject to Justice. We leave it to each individual to observe for themselves the degree to which they and their associates are surviving well or poorly, and how marijuana may contribute to or obstruct the quality of their life.

In a statement issued January 13, 2019, the Cleveland Clinic announced that it will not be recommending medical marijuana to its patients. Dr. Paul Terpeluk, medical director of employee health services at the Cleveland Clinic, said, “There is little verified, published research that supports marijuana…as a medical treatment. … However, there is a significant amount of scientific literature that unequivocally shows that marijuana use has both short- and long-term deleterious effects on physical health.”

There are alternatives. We urge everyone embarking on some course of treatment to do their due diligence and undertake full informed consent.

High Anxiety

We recently watched the classic Mel Brooks movie “High Anxiety.” Besides the fact that it is absolutely hilarious, and relentlessly parodies psychiatry and psychiatrists, it also leads into a discussion of anxiety as popularized by psychiatry and psychology.

The American Psychological Association says, “Anxiety is an emotion characterized by feelings of tension, worried thoughts and physical changes like increased blood pressure. People with anxiety disorders usually have recurring intrusive thoughts or concerns. They may avoid certain situations out of worry. They may also have physical symptoms such as sweating, trembling, dizziness or a rapid heartbeat.”

The American Psychiatric Association says, “Anxiety is a normal reaction to stress … Anxiety disorders differ from normal feelings of nervousness or anxiousness, and involve excessive fear or anxiety.” But they go further and list many different types of anxiety disorders. The Diagnostic and Statistical Manual of Mental Disorders (DSM) lists no fewer than 54 disorders using the word “anxiety,” plus a number of other disorders with different names but which may still be considered as a type of anxiety disorder.

Psychiatrist Dr. Richard H. Thorndyke, played by Mel Brooks in the movie, suffers from “high anxiety,” manifested as vertigo ostensibly from a fear of heights, which in the DSM would be a “Specific phobia.”

The English word “anxiety” itself means, among other definitions, “apprehensive uneasiness, worry, or nervousness typically over an impending or anticipated ill, or something with an uncertain outcome.” [Latin anxietas, from anxius, from angere “to choke”]

Psychiatrists and psychologists attempt to give it a “medical” definition, which is necessary in order to prescribe drugs for it. One medical dictionary says this, “Anxiety disorder: A chronic condition characterized by an excessive and persistent sense of apprehension, with physical symptoms such as sweating, palpitations, and feelings of stress. Treatments include the comfort offered by understanding the condition, avoiding or desensitizing exacerbating situations, and medications.” Google says this, “a nervous disorder characterized by a state of excessive uneasiness and apprehension, typically with compulsive behavior or panic attacks.”

The relationship of anxiety to stress should be self-evident. You might like to review what we have written previously about stress.

Anxiety, like stress, is not a mental illness, and cannot be fixed with a drug. It can only be fixed by finding and eliminating the causes of the condition. For example, many doctors and nutritionists are finding that anxiety attack symptoms can be the result of food allergies. There are many other potential causes. We recommend a full, searching clinical examination by a competent non-psychiatric doctor, to find out if there are any undiagnosed and untreated actual medical conditions.

There is an international nonprofit organization called “Anxiety and Depression Association of America”, whose purpose is the prevention, treatment, and cure of anxiety and other “co-occurring  disorders.” Naturally they claim, falsely, that anxiety disorders have a biological basis, giving them a reason to prescribe drugs. The National Institute of Mental Health says, “Anxiety disorders are generally treated with psychotherapy, medication, or both.”

If you were thinking of an anti-anxiety drug, be warned that these can cause hallucinations, delusional thinking, confusion, aggression, violence, hostility, agitation, irritability, depression and suicidal thinking. They are also some of the most difficult drugs to withdraw from.

Anxiety is an emotion, and is really a conflict, or the restimulation of a conflict, or something containing indecision or uncertainty. It is exemplified by a conflict between something supporting survival and something opposing survival. It is rooted in an inability to assign the correct cause to something, which itself is rooted in an inability to observe. As we said, the cure is not a drug, but in finding out the correct cause.

Be Well.

Neurodiversity – The Latest Psychiatric Disability Trend

We’ve written a considerable amount previously about topics involving various disabilities and their relation to psychiatric fraud and abuse; here is a small selection for example:

People With Disabilities

The Disabled Community has many advocates helping them survive better in the world. The Americans with Disabilities Act (ADA) defines a disability as “a physical or mental impairment that substantially limits one or more major life activities”. Traditional physical disabilities such as blindness, deafness, missing or impaired body parts, all have their advocates.

However, the psychiatric industry has made it their special emphasis to target people with so-called mental disabilities: Autism, PTSD, Learning Disabilities, Dyslexia (problems with reading), ADHD, Dyspraxia (problems with movement or coordination), Dyscalculia (problems with mathematics), Tourette Syndrome (involuntary, repetitive movements and vocalizations), Hydrocephalus (a buildup of fluid in the brain.)

Neurodiversity

With so many different “mental disorders” and no real clues about curing them, psychiatrists needed a new all-encompassing word to describe them. They picked “neurodiversity” — diversity based on some neurological condition.

Neurodiversity is a concept where neurological differences are to be recognized and respected as any other human variation. Neurodiversity activists may reject the idea that any of these conditions should be cured, since they don’t know how to do so, advocating instead for support systems that help people get along in life with their disability.

Now, we’re not advocating for any particular support system, and we certainly think that helping people with disabilities get along better in life is a laudable activity and deserves support.

Psychiatry

One theory of biological psychiatry is that these various neurological conditions are the result of normal variations in the human genome. Unfortunately, this attitude tends to lean toward eugenics, which is the track taken in Nazi Germany to eliminate anyone with so-called genetic defects from the breeding population. Psychiatrists developed the racial purity ideology used by Hitler which lead to the Nazi euthanasia program and, later, ethnic cleansing in the Balkans.

We question whether the psychiatric industry has anyone’s best interests at heart, let alone the interests of the disabled. In 2009, the Florida Sun Sentinel reported about the use of dangerous prescription medications for children and adults in residential and group home facilities licensed by the Florida Agency for Persons with Disabilities.

In 1987, “Attention Deficit Hyperactivity Disorder” (ADHD) was literally voted into existence by a show of hands of American Psychiatric Association members and included in the Diagnostic and Statistical Manual of Mental Disorders (DSM). Within a year, 500,000 children in America alone were diagnosed with this, and to expand the client base it has also been associated with Asperger syndrome and Autism spectrum disorder.

In 2018, the media reported on a Massachusetts school [Judge Rotenberg Educational Center in Canton, MA] which will be allowed to continue administering electric shocks to its special needs students after a judge ruled the procedure conformed to the “accepted standard of care,” in spite of the practice being condemned by disability rights groups and the ACLU.

[Update 3 December 2018] On December 3, 2018, the Inter-American Commission on Human Rights of The Organization of American States published a Precautionary Measure calling for the Judge Rotenberg Educational Center in Canton, Massachusetts to immediately cease electroshocking special needs children as a disciplinary measure.

Our Point

The psychiatric industry continues to find new patient populations in the disability community, and imposes coercive and damaging “treatments” that further compromise people’s mental and physical health.

A parent with a child on psychotropic drugs can receive disability payments as a financial incentive. We observe that psychiatric drugs cause disability, regardless of any pre-existing conditions.

Even the United Nations recognizes the pervasiveness of abuse in the mental health care system. In its July 24, 2018 Annual Report of the High Commissioner, “Mental health and human rights,” it states, “States should ensure that all health care and services, including all mental health care and services, are based on the free and informed consent of the individual concerned, and that legal provisions and policies permitting the use of coercion and forced interventions, including involuntary hospitalization and institutionalization, the use of restraints, psychosurgery, forced medication, and other forced measures aimed at correcting or fixing an actual or perceived impairment, including those allowing for consent or authorization by a third party, are repealed. States should reframe and recognize these practices as constituting torture or other cruel, inhuman or degrading treatment or punishment and as amounting to discrimination against users of mental health services, persons with mental health conditions and persons with psychosocial disabilities.”

We rest our case. We need your help. Let us know if you have some volunteer hours to help us expose psychiatric fraud and abuse.

Guilty of Bad Taste

And we don’t mean the “Bad Taste” 1987 science-fiction comedy horror splatter film about aliens harvesting humans for their intergalactic fast food franchise.

We mean that something is in bad or poor taste when it exhibits poor judgment by being tasteless, unsuitable, unseemly, improper, inappropriate, politically incorrect, impolite, lewd, offensive, insensitive, vulgar, crude, rude, obscene, meanspirited, or uncalled for. It is not a morally wrong action, but the reporting of current events often hypes what is essentially just bad taste by elevating it to a crime or a mental illness.

It should be obvious that the judgment of what is in good or bad taste is pretty subjective, socially entangled, and can be described by hoards of synonymous words.

Of course, we all know what good taste is. It’s what we have, and other people don’t.

Then again, bad taste could just be a failure to police oneself due to some extremely distracting condition, such as intoxication.

It occurred to us, reviewing some of the recent “news” in main stream media, that psychiatry has been (horrors) guilty of labeling bad taste as mental disorders.

Here are some examples of what could be just incidents of bad taste, or related to incidents of bad taste, from the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). These are the fraudulent psychiatric diagnoses for which harmful and addictive psychotropic drugs can be prescribed, and for which insurance will pay the cost.

Adult antisocial behavior
Alcohol intoxication
Caffeine intoxication
Caffeine withdrawal
Cannabis intoxication
Cannabis withdrawal
Child or adolescent antisocial behavior
Cocaine intoxication
Cocaine withdrawal
Conduct disorder
Discord with neighbor, lodger, or landlord
Disinhibited social engagement disorder
Exhibitionistic disorder
Histrionic personality disorder
Insomnia disorder
Intermittent explosive disorder
Narcissistic personality disorder
Opioid intoxication
Opioid withdrawal
Personal history of military deployment
Phase of life problem
Relationship distress with spouse or intimate partner
Sibling relational problem
Social exclusion or rejection
Target of (perceived) adverse discrimination or persecution
Tobacco withdrawal

There are undoubtedly more diagnoses that could fit this categorization.

In other words, by exhibiting bad taste one could be diagnosed with a mental disorder and prescribed harmful and addictive psychotropic drugs. And who among us has not slipped up and said something they later regret? The point is, bad taste is not a mental illness, but it has been used by the psychiatric industry as a money-maker and a control mechanism by psychiatrists who assert that they know how you should behave in every circumstance.

With the DSM, psychiatry has taken countless aspects of human behavior and reclassified them as a “mental illness” simply by adding the term “disorder” onto them. While even key DSM contributors admit that there is no scientific or medical validity to the “disorders,” the DSM nonetheless serves as a diagnostic tool, not only for individual treatment, but also for child custody disputes, discrimination cases, court testimony, education, immigration, and more. As the diagnoses completely lack scientific criteria, anyone can be labeled mentally ill, and subjected to dangerous and life threatening “treatments” based solely on opinion.

It used to be that the term “mentally ill” was limited to mean crazy people like those talking to themselves in the streets and those acting irrationally, oblivious to the world around them. However, the symptoms of mental illness, today, have been re-defined and broadened by psychiatry to fit under the umbrella of any non-optimum behavior, including what is considered normal for that age. Basically, “mentally ill” now is just an opinion about something that a psychiatrist doesn’t like.

Since there is no laboratory test that can identify mental illness or suicide risk, the diagnosis of a mental disorder or of a suicide risk is entirely subjective. Basically, it is the opinion of a psychiatrist who has decided he does not like what a person is thinking or feeling. This is what we mean when we say that psychiatry is being used as a social control mechanism.

The psychiatricizing of normal everyday behavior by including personality quirks and traits is a lucrative business for the American Psychiatric Association because by expanding the number of “mental illnesses” even ordinary people can become patients and added to the psychiatric marketing pool.

People can and do experience depression, anxiety and sadness, children (and adults) do act out or misbehave, and some people can indeed become irrational or psychotic, or be guilty of bad taste. This does not make them “diseased.” There are non–psychiatric, non–drug solutions for people experiencing mental difficulty, there are non–harmful alternatives.